UnitedHealth Group Inc (NYSE:UNH) Stock Holdings Raised by Lindbrook Capital LLC

Lindbrook Capital LLC raised its position in UnitedHealth Group Inc (NYSE:UNH) by 19.7% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,379 shares of the healthcare conglomerate’s stock after purchasing an additional 227 shares during the quarter. Lindbrook Capital LLC’s holdings in UnitedHealth Group were worth $340,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Crewe Advisors LLC acquired a new stake in shares of UnitedHealth Group during the fourth quarter worth about $25,000. Pearl River Capital LLC acquired a new stake in shares of UnitedHealth Group during the fourth quarter worth about $35,000. Canton Hathaway LLC acquired a new stake in shares of UnitedHealth Group during the first quarter worth about $36,000. Laurel Wealth Advisors LLC acquired a new stake in shares of UnitedHealth Group during the fourth quarter worth about $42,000. Finally, Truvestments Capital LLC acquired a new stake in shares of UnitedHealth Group during the first quarter worth about $42,000. 85.63% of the stock is currently owned by institutional investors.

In related news, Director William C. Ballard, Jr. sold 5,000 shares of the firm’s stock in a transaction that occurred on Monday, May 6th. The shares were sold at an average price of $239.02, for a total transaction of $1,195,100.00. Following the sale, the director now owns 77,993 shares in the company, valued at $18,641,886.86. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Richard T. Burke sold 10,000 shares of the firm’s stock in a transaction that occurred on Wednesday, April 24th. The stock was sold at an average price of $229.75, for a total transaction of $2,297,500.00. Following the sale, the director now owns 187,663 shares in the company, valued at approximately $43,115,574.25. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 35,000 shares of company stock worth $8,392,500. 0.87% of the stock is owned by company insiders.

Several equities research analysts have recently weighed in on the stock. Zacks Investment Research upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $265.00 target price for the company in a research note on Friday, May 17th. Bank of America reissued a “buy” rating and set a $290.00 price target (down from $320.00) on shares of UnitedHealth Group in a report on Wednesday, April 17th. SunTrust Banks cut their price target on shares of UnitedHealth Group to $300.00 and set a “buy” rating for the company in a report on Wednesday, April 17th. They noted that the move was a valuation call. ValuEngine cut shares of UnitedHealth Group from a “hold” rating to a “sell” rating in a report on Thursday, April 18th. Finally, Citigroup cut their price target on shares of UnitedHealth Group from $288.00 to $247.00 and set a “neutral” rating for the company in a report on Wednesday, April 17th. One analyst has rated the stock with a sell rating, two have assigned a hold rating, eighteen have assigned a buy rating and one has issued a strong buy rating to the stock. The company has an average rating of “Buy” and an average price target of $290.84.

Shares of UNH traded down $2.33 during mid-day trading on Friday, reaching $244.01. 6,199,748 shares of the company’s stock were exchanged, compared to its average volume of 4,909,266. The company has a debt-to-equity ratio of 0.63, a quick ratio of 0.73 and a current ratio of 0.73. The stock’s 50-day simple moving average is $244.90. UnitedHealth Group Inc has a 52-week low of $208.07 and a 52-week high of $287.94. The company has a market cap of $231.38 billion, a P/E ratio of 18.94, a price-to-earnings-growth ratio of 1.30 and a beta of 0.66.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $3.73 earnings per share for the quarter, topping the Zacks’ consensus estimate of $3.60 by $0.13. UnitedHealth Group had a net margin of 5.45% and a return on equity of 25.07%. The business had revenue of $60.30 billion during the quarter, compared to analysts’ expectations of $59.72 billion. During the same period last year, the company posted $3.04 EPS. The company’s revenue was up 9.2% on a year-over-year basis. On average, equities research analysts predict that UnitedHealth Group Inc will post 14.71 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which was paid on Tuesday, June 25th. Investors of record on Monday, June 17th were given a dividend of $1.08 per share. The ex-dividend date of this dividend was Friday, June 14th. This represents a $4.32 dividend on an annualized basis and a yield of 1.77%. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $0.90. UnitedHealth Group’s dividend payout ratio (DPR) is 33.54%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Read More: Gap Down Stocks

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.